$SBRA

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of “Moderate Buy” from Brokerages

Sabra Healthcare REIT (NASDAQ: SBRA) received a consensus “Moderate Buy” rating from 10 analysts, with five “hold” and five “buy” ratings, according to MarketBeat. The average 12-month target price is $22.30. Wells Fargo and UBS raised targets to $22; Citigroup to $24. SBRA reported $0.16 EPS on $211.74M revenue and paid a $0.30 quarterly dividend (6% yield).

Original reporting
Published May 30, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 30, 2026, 11:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of “Moderate Buy” from Brokerages — source image
Decision brief

The 30-second read

$SBRABullishLow
01

Why it matters

For traders, the only actionable element is sentiment/expectations drift (consensus Moderate Buy; average target $22.30) rather than a fresh operational or financial datapoint.

02

Market read

Moderate Buy consensus and higher targets may support near-term sentiment, but the article lacks a new catalyst beyond analyst framing.

03

What to watch

Dividend payout ratio (~190%) and REIT leverage/interest-rate sensitivity could cap upside even if targets rise.

Relevance 6/10Novelty 4/10Timing: today’s analyst-consensus/target recap

Background

The piece compiles consensus ratings, recent broker target adjustments, institutional ownership changes, and selected fundamentals (earnings, guidance, dividend).

Company-level read

Ticker impact

$SBRABullishMedium confidence
Context

Consensus “Moderate Buy” and multiple broker target changes (e.g., Citi to $24) update Street expectations for Sabra Healthcare REIT.

Expected impact

Likely modest upward bias/mean-reversion support rather than a catalyst-driven breakout.

Evidence & confidence

The article is primarily an analyst-rating/target recap; it does not report new earnings, guidance, deals, or regulatory actions beyond already-known quarterly results and FY 2026 EPS range.

Market effects

Reinforces cautious optimism toward healthcare REIT net-lease demand, but provides no sector-wide regulatory or macro shock.

None indicated.

None indicated.

Counterpoint

Analyst target hikes may already be priced; without new fundamentals, the stock may trade more on rates/credit than on rating changes.

Key entities

  • Sabra Healthcare REIT, Inc.

    NASDAQ-listed healthcare REIT subject of the consensus rating, target-price updates, and dividend/earnings recap.

Related articles

$SBRAMed

Sabra Health Care REIT, Inc. (SBRA): Results of Operations and Financial Condition

Sabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 sbraex9932026q2.htm Q2 2026 NON-GAAP RECONCILIATIONS Document Reconciliations of Non-GAAP Financial Measures June 30, 2026 (Unaudited) SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES 2026 OUTLOOK FFO, Normalized FFO, AFFO and Normalized AFFO

$SBRAMedAI 8/10

Why Sabra Health Care REIT Stock Soared Today

Sabra Health Care REIT (SBRA) shares rose over 10% after the company issued an operational update. Sabra said it signed letters of intent to retenant 26 Avamere properties, targeting $53M annual rent versus $41M prior. It also arranged to retire a $300M RCA mortgage with $200M cash. Sabra raised 2026 guidance to $0.37-$0.39 headline net income and $1.59-$1.61 normalized AFFO.

$TTWOMed

Grand Theft Auto 6 Details Emerge Before Netflix Reveal

Take-Two Interactive said pre-orders for Grand Theft Auto VI have exceeded internal forecasts, without disclosing a figure. It kept its fiscal 2027 net bookings outlook at $8.0 to $8.2 billion and reported Q1 FY2027 revenue of $1.39 billion. GTA VI’s Netflix extended look is set for Aug. 27, with release on Nov. 19, 2026.

$UAAMed

What Is Under Armour (UAA) Changing After Its Sales Outlook Cut?

Simply Wall St reports Under Armour (NYSE:UAA) cut its full-year sales outlook due to weaker global demand in North America, Asia Pacific and EMEA. The company is simplifying its business by streamlining products and tightening expenses. Management kept its operating income outlook at US$96 million to US$116 million, with investors watching results through March 31, 2027.

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.